Trident® X3 Polyethylene Insert Study

NCT00958191 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 250

Last updated 2018-02-23

Study results available
· View outcomes & findings →

Summary

The primary objective of the study is to demonstrate the linear wear rates of the Trident® X3 polyethylene insert are superior to a polyethylene control group wear rate at 5 years postoperative. This measurement will be evaluated by comparing digitized images of serial radiographs obtained over a follow-up period of 5-years.

Conditions

  • Arthroplasty, Replacement, Hip

Interventions

DEVICE

Trident® X3 Polyethylene Insert

Trident® X3 Polyethylene Insert

Sponsors & Collaborators

  • Stryker Orthopaedics

    lead INDUSTRY

Principal Investigators

  • James D'Antonio, MD · Greater Pittsburgh Orthopaedic Association

  • Benjamin Bierbaum, MD · New England Baptist Hospital Deptartment of Orthopaedics

  • Peter Bonutti, MD · Bonutti Clinic

  • William Capello, MD · Indiana University School of Medicine

  • Michael Taunton, MD · Mayo Clinic Department of Orthopaedic Surgery

  • Robert Johnson, MD · University of Vermont College of Medicine Department of Orthopaedics & Rehabilitation

  • J. Wesley Mesko, MD · Michigan Orthopaedic Center

  • James R Roberson, MD · Emory Orthopaedics

  • John Wright, MD · New West Orthopaedics

  • Daniel Ward, MD · New England Baptist Hospital Department of Orthopaedics

  • Russell Meldrum, MD · Indiana University School of Medicine

  • J. Andrew Parr, MD · Indiana University School of Medicine

  • Steven Incavo, MD · University of Vermont

  • Greg Erens, MD · Emory Orthopaedics

  • Robert Trousdale, MD · Mayo Clinic Department of Orthopaedic Surgery

  • Alren Hanssen, MD · Mayo Clinic Department of Orthopaedic Surgery

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
21 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-05-31
Primary Completion
2012-07-31
Completion
2016-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00958191 on ClinicalTrials.gov